Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
valuation ratios | |
|---|---|
| pe ratio | -8.10 |
| peg ratio | 1.84 |
| price to book ratio | 3.80 |
| price to sales ratio | 24.73 |
| enterprise value multiple | -8.25 |
| price fair value | 3.80 |
profitability ratios | |
|---|---|
| gross profit margin | 71.85% |
| operating profit margin | -343.3% |
| pretax profit margin | -313.19% |
| net profit margin | -313.65% |
| return on assets | -34.46% |
| return on equity | -63.39% |
| return on capital employed | -45.33% |
liquidity ratio | |
|---|---|
| current ratio | 5.28 |
| quick ratio | 5.28 |
| cash ratio | 1.15 |
efficiency ratio | |
|---|---|
| days of inventory outstanding | 0.00 |
| operating cycle | 0.00 |
| days of payables outstanding | 90.04 |
| cash conversion cycle | -90.04 |
| receivables turnover | 0.00 |
| payables turnover | 4.05 |
| inventory turnover | 0.00 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.05 |
| debt equity ratio | 0.07 |
| long term debt to capitalization | 0.00 |
| total debt to capitalization | 0.07 |
| interest coverage | -24.56 |
| cash flow to debt ratio | -3.76 |
cash flow ratios | |
|---|---|
| free cash flow per share | -1.54 |
| cash per share | 6.16 |
| operating cash flow per share | -1.40 |
| free cash flow operating cash flow ratio | 1.10 |
| cash flow coverage ratios | -3.76 |
| short term coverage ratios | -15.58 |
| capital expenditure coverage ratio | -10.47 |
Frequently Asked Questions
Nurix Therapeutics, Inc. (NRIX) published its most recent earnings results on 11-10-2024.
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Nurix Therapeutics, Inc. (NASDAQ:NRIX)'s trailing twelve months ROE is -63.39%.
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Nurix Therapeutics, Inc. (NRIX) currently has a ROA of -34.46%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
NRIX reported a profit margin of -313.65% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
Apple's current ratio, which measures its ability to pay short-term obligations, was 5.28 in the most recent quarter. The quick ratio stood at 5.28, with a Debt/Eq ratio of 0.07.